{"id":"https://openalex.org/W7225750154","doi":"https://doi.org/10.1177/10507256261500974","title":"Lymphopenia and Circulating Biomarker Dynamics Associated with Clinical Outcome and Toxicity in Pazopanib-Treated Radioiodine-Refractory Thyroid Cancer: Exploratory Analyses from the Pazothyr Trial","display_name":"Lymphopenia and Circulating Biomarker Dynamics Associated with Clinical Outcome and Toxicity in Pazopanib-Treated Radioiodine-Refractory Thyroid Cancer: Exploratory Analyses from the Pazothyr Trial","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225750154","doi":"https://doi.org/10.1177/10507256261500974","pmid":"https://pubmed.ncbi.nlm.nih.gov/43007078"},"language":"en","primary_location":{"id":"doi:10.1177/10507256261500974","doi":"https://doi.org/10.1177/10507256261500974","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10507256261500974","pdf_url":null,"source":{"id":"https://openalex.org/S27569427","display_name":"Thyroid","issn_l":"1050-7256","issn":["1050-7256","1557-9077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thyroid\u00ae","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073202802","display_name":"C\u00e9line Rodriguez","orcid":"https://orcid.org/0000-0002-6438-474X","observed_orcids":["https://orcid.org/0000-0002-6438-474X","https://orcid.org/0000-0001-7358-6792"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C\u00e9line Rodriguez","raw_affiliation_strings":["Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035359860","display_name":"C\u00e9cile Dalban","orcid":"https://orcid.org/0009-0006-3979-7645","observed_orcids":["https://orcid.org/0009-0006-3979-7645"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C\u00e9cile Dalban","raw_affiliation_strings":["Department of Clinical Research and Innovation, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research and Innovation, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039678433","display_name":"Am\u00e9lie Colombe\u2010Vermorel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Am\u00e9lie Colombe-Vermorel","raw_affiliation_strings":["PATHEC, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PATHEC, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016038823","display_name":"Laetitia Odeyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laetitia Odeyer","raw_affiliation_strings":["PATHEC, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PATHEC, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073301416","display_name":"Livia Lamartina","orcid":"https://orcid.org/0000-0003-3640-1204","observed_orcids":["https://orcid.org/0000-0003-3640-1204"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Livia Lamartina","raw_affiliation_strings":["Medical Imaging Department, Endocrine Cancerology Department, Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Imaging Department, Endocrine Cancerology Department, Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007700455","display_name":"Yann Godbert","orcid":"https://orcid.org/0009-0007-8385-2952","observed_orcids":["https://orcid.org/0009-0007-8385-2952"]},"institutions":[{"id":"https://openalex.org/I4210134409","display_name":"Institut Bergoni\u00e9","ror":"https://ror.org/02yw1f353","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134409"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yann Godbert","raw_affiliation_strings":["Nuclear Medicine and Endocrine Oncology Department, Institut Bergoni\u00e9, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine and Endocrine Oncology Department, Institut Bergoni\u00e9, Bordeaux, France","institution_ids":["https://openalex.org/I4210134409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044089887","display_name":"F. Illouz","orcid":"https://orcid.org/0000-0002-5676-0127","observed_orcids":["https://orcid.org/0000-0002-5676-0127"]},"institutions":[{"id":"https://openalex.org/I4210112910","display_name":"Centre Hospitalier Universitaire d'Angers","ror":"https://ror.org/0250ngj72","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210112910"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Frederic Illouz","raw_affiliation_strings":["Department of Endocrinology, CHU Angers, Angers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, CHU Angers, Angers, France","institution_ids":["https://openalex.org/I4210112910"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069317933","display_name":"Julien Gautier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Julien Gautier","raw_affiliation_strings":["Department of Clinical Research and Innovation, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research and Innovation, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079971350","display_name":"Isabelle Treilleux","orcid":"https://orcid.org/0000-0003-3919-5506","observed_orcids":["https://orcid.org/0000-0003-3919-5506"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Treilleux","raw_affiliation_strings":["Anatomo-pathology Department, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","PATHEC, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anatomo-pathology Department, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"PATHEC, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072885787","display_name":"Sophie Darnis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Darnis","raw_affiliation_strings":["Department of Clinical Research and Innovation, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Research and Innovation, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025970784","display_name":"Christophe Caux","orcid":"https://orcid.org/0000-0003-2438-833X","observed_orcids":["https://orcid.org/0000-0003-2438-833X"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Caux","raw_affiliation_strings":["Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060536774","display_name":"Christelle de la Fouchardi\u00e8re","orcid":"https://orcid.org/0000-0003-2291-5693","observed_orcids":["https://orcid.org/0000-0003-2291-5693"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christelle de la Fouchardi\u00e8re","raw_affiliation_strings":["Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025761056","display_name":"Christine M\u00e9n\u00e9trier\u2010Caux","orcid":"https://orcid.org/0000-0003-4863-374X","observed_orcids":["https://orcid.org/0000-0003-4863-374X"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Christine M\u00e9n\u00e9trier-Caux","raw_affiliation_strings":["Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, L\u00e9on B\u00e9rard Cancer Center, Lyon, France"],"raw_orcid":"https://orcid.org/0000-0003-4863-374X","affiliations":[{"raw_affiliation_string":"Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, L\u00e9on B\u00e9rard Cancer Center, Lyon, France","institution_ids":["https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5025761056"],"corresponding_institution_ids":["https://openalex.org/I4210105738","https://openalex.org/I4210125048"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"10507256261500974","last_page":"10507256261500974"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.8704000115394592},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7957000136375427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6583999991416931},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6467999815940857},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5737000107765198},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5103999972343445},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.4652999937534332},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4059000015258789},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3698999881744385},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.3305000066757202},{"id":"https://openalex.org/C68324877","wikidata":"https://www.wikidata.org/wiki/Q421859","display_name":"Interleukin 8","level":3,"score":0.32010000944137573},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.31690001487731934},{"id":"https://openalex.org/C11988809","wikidata":"https://www.wikidata.org/wiki/Q412889","display_name":"Interleukin 6","level":3,"score":0.3138999938964844},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.31299999356269836},{"id":"https://openalex.org/C2993294228","wikidata":"https://www.wikidata.org/wiki/Q13632630","display_name":"Thyroid carcinoma","level":3,"score":0.2971000075340271},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.289900004863739},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.2881999909877777},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2867000102996826},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.28209999203681946},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.28049999475479126},{"id":"https://openalex.org/C2779761222","wikidata":"https://www.wikidata.org/wiki/Q826522","display_name":"Thyroid cancer","level":3,"score":0.27970001101493835},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27480000257492065},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.26649999618530273},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.25060001015663147}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1177/10507256261500974","doi":"https://doi.org/10.1177/10507256261500974","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10507256261500974","pdf_url":null,"source":{"id":"https://openalex.org/S27569427","display_name":"Thyroid","issn_l":"1050-7256","issn":["1050-7256","1557-9077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thyroid\u00ae","raw_type":"journal-article"},{"id":"pmid:43007078","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/43007078","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thyroid : official journal of the American Thyroid Association","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W194397696","https://openalex.org/W1571830205","https://openalex.org/W1967792499","https://openalex.org/W1972160639","https://openalex.org/W1982906652","https://openalex.org/W2005719789","https://openalex.org/W2007990687","https://openalex.org/W2008196398","https://openalex.org/W2019607817","https://openalex.org/W2029169364","https://openalex.org/W2029717031","https://openalex.org/W2033283549","https://openalex.org/W2035387891","https://openalex.org/W2060408251","https://openalex.org/W2079201443","https://openalex.org/W2089692311","https://openalex.org/W2092549386","https://openalex.org/W2109197651","https://openalex.org/W2115682969","https://openalex.org/W2148237316","https://openalex.org/W2153064305","https://openalex.org/W2164001237","https://openalex.org/W2168076926","https://openalex.org/W2341622444","https://openalex.org/W2437992816","https://openalex.org/W2531627693","https://openalex.org/W2556903147","https://openalex.org/W2572623634","https://openalex.org/W2589693271","https://openalex.org/W2604320765","https://openalex.org/W2624599834","https://openalex.org/W2735625431","https://openalex.org/W2760330862","https://openalex.org/W2767493769","https://openalex.org/W2884883038","https://openalex.org/W2907478497","https://openalex.org/W2923091794","https://openalex.org/W2943769232","https://openalex.org/W2976163596","https://openalex.org/W2994808935","https://openalex.org/W3008495314","https://openalex.org/W3029486018","https://openalex.org/W3046600912","https://openalex.org/W3092164039","https://openalex.org/W3097994133","https://openalex.org/W3124581135","https://openalex.org/W3131928172","https://openalex.org/W3136543556","https://openalex.org/W3138589612","https://openalex.org/W3163984610","https://openalex.org/W3166517207","https://openalex.org/W3170771910","https://openalex.org/W3179200118","https://openalex.org/W3201577044","https://openalex.org/W3205433234","https://openalex.org/W4200254340","https://openalex.org/W4280598129","https://openalex.org/W4293525779","https://openalex.org/W4306777542","https://openalex.org/W4309533549","https://openalex.org/W7117370897"],"related_works":[],"abstract_inverted_index":{"Background:":[0],"Pazopanib":[1],"showed":[2],"clinical":[3,67,371],"activity":[4],"in":[5,36,54,113,216,306,376,390],"progressive":[6],"radioiodine-refractory":[7],"differentiated":[8],"thyroid":[9],"carcinoma":[10],"(RAIR-DTC),":[11],"although":[12],"its":[13],"use":[14],"is":[15],"limited":[16],"by":[17,22,111],"substantial":[18,146,231,332,382],"toxicity":[19,35],"not":[20],"reduced":[21],"intermittent":[23],"treatment.":[24],"We":[25,57],"aimed":[26],"to":[27,46],"identify":[28],"biomarkers":[29,367],"associated":[30,175,209,229,266,301,330,358,369,380],"with":[31,123,137,176,195,210,230,267,302,331,336,359,370,381,394],"outcome":[32],"and":[33,60,79,89,93,108,145,171,192,206,226,252,289,318,364],"treatment-related":[34,147],"these":[37],"patients.":[38,56],"Methods:":[39],"This":[40],"study":[41],"reported":[42],"exploratory":[43,155,385],"results":[44,386],"related":[45],"the":[47,65,154],"Pazothyr":[48,66],"trial":[49],"(NCT01813136)":[50],"investigating":[51],"pazopanib":[52,98,132,395],"efficacy":[53],"RAIR-DTC":[55,391],"evaluated":[58],"lymphopenia":[59,173,238,363],"neutrophil-to-lymphocyte":[61],"ratio":[62,240,309],"(NLR)":[63],"from":[64,117],"database":[68],"(":[69,99,119],"n":[70,100,120],"=":[71,101,121,242,250,256,261,273,278,282,287,292,297,311,316,321,326,349,354],"168).":[72],"Dedicated":[73],"informed":[74],"consent":[75],"for":[76,162,407],"additional":[77],"plasma":[78,86,366],"tumor":[80,337],"sample":[81],"collection":[82],"allowed":[83],"quantification":[84],"of":[85,97,131,157,404],"angiogenic":[87],"factors":[88,265,378],"cytokines":[90],"at":[91],"baseline":[92,236,270],"after":[94,128],"one":[95],"month":[96],"111).":[102],"Immune":[103],"markers":[104],"(CD8,":[105],"FOXP3,":[106],"CD163,":[107],"PDL1)":[109],"analyzed":[110],"immunohistochemistry":[112],"archived":[114],"primary":[115],"tumors":[116],"patients":[118,335,392],"68)":[122],"response":[124],"or":[125,246,396],"stable":[126],"disease":[127],"6":[129,190],"months":[130],"were":[133,151,174,208,228,299,328,368,379],"scored":[134],"semiquantitatively.":[135],"Associations":[136],"response,":[138],"progression-free":[139],"survival":[140,143],"(PFS),":[141],"overall":[142],"(OS),":[144],"adverse":[148],"events":[149],"(TRAEs)":[150],"evaluated.":[152],"Given":[153],"nature":[156],"this":[158],"study,":[159],"no":[160],"adjustment":[161],"multiple":[163],"comparisons":[164],"was":[165,356],"performed.":[166],"Results:":[167],"At":[168],"baseline,":[169],"moderate":[170],"severe":[172,237],"shorter":[177,211],"PFS,":[178],"unlike":[179],"high":[180,253],"NLR.":[181],"Elevated":[182],"Vascular":[183],"Endothelial":[184],"Growth":[185],"Factor":[186],"A":[187],"(VEGF-A),":[188],"Interleukin":[189],"(IL-6),":[191],"CXCL8":[193,254,290],"correlated":[194],"poorer":[196],"PFS.":[197],"High":[198,269],"VEGF-A,":[199],"hepatocyte":[200],"growth":[201,218],"factor":[202,219],"(HGF),":[203],"IL-6,":[204],"CXCL8,":[205],"CXCL9":[207],"OS.":[212],"X":[213],"Early":[214],"changes":[215,375],"placental":[217],"(PlGF),":[220],"HGF,":[221],"interleukin":[222],"12":[223],"subunit":[224],"p40,":[225],"CXCL10":[227],"TRAEs.":[232,333,383],"Multivariable":[233],"analyses":[234],"identified":[235],"(hazard":[239],"[HR]":[241],"2.39":[243],"[confidence":[244],"interval":[245],"CI":[247],"1.27\u20134.48],":[248],"p":[249,260,277,286,296,315,325,353],"0.007)":[251],"(HR":[255,272,281,291,348],"2.01":[257],"[CI":[258,275,284,294,313,323,351],"1.26\u20133.21],":[259],"0.004)":[262],"as":[263],"independent":[264],"progression.":[268,360],"NLR":[271],"2.26":[274],"1.21\u20134.22],":[276],"0.01),":[279],"HGF":[280,319],"2.37":[283],"1.33\u20134.20],":[285],"0.003),":[288],"2.20":[293],"1.25\u20133.87],":[295],"0.006)":[298],"similarly":[300],"death.":[303],"One-month":[304],"increases":[305],"PlGF":[307],"(odds":[308],"[OR]":[310],"2.49":[312],"1.13\u20135.50],":[314],"0.024)":[317],"(OR":[320],"2.91":[322],"1.32\u20136.43],":[324],"0.008)":[327],"independently":[329],"In":[334],"samples,":[338],"Programmed":[339],"cell":[340,344],"Death-Ligand":[341],"1":[342],"(PDL1)-immune":[343],"score":[345],"(ICS)":[346],">1%":[347],"2.05":[350],"1.15\u20133.66],":[352],"0.015)":[355],"also":[357],"Conclusions:":[361],"Baseline":[362],"inflammatory":[365],"outcome,":[372],"whereas":[373],"early":[374],"circulating":[377],"These":[384],"require":[387],"prospective":[388,412],"validation":[389],"treated":[393],"other":[397],"VEGF":[398],"receptor-targeting":[399],"multikinase":[400],"inhibitors.":[401],"The":[402],"relevance":[403],"PDL1-ICS":[405],"expression":[406],"anti-PD1/PDL1-based":[408],"therapies":[409],"requires":[410],"dedicated":[411],"trials.":[413]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}